Current through Register Vol. 56, No. 21, November 4, 2024
Section 13:45H-1.3 - Activities requiring registration(a) Registration under 13:45H-1.2(a) or (b) shall be issued to authorize the registrant to manufacture, distribute or act as a reverse distributor of, respectively, specific controlled dangerous substances included in Schedule I or Schedule II, or to authorize the registrant to manufacture, distribute or act as a reverse distributor of, respectively, the controlled dangerous substances included in Schedules III, IV, or V. Any registrant authorized to manufacture, distribute or act as a reverse distributor of substances included in Schedules III, IV, or V may manufacture, distribute or act as a reverse distributor of, respectively, any controlled dangerous substance listed in the Schedule or Schedules for which he is registered.(b) A person desiring to obtain a registration under 13:45H-1.2(a) or (b) shall specify the controlled dangerous substances or the Schedules for which he wishes to obtain a registration in his application and may manufacture, distribute or act as a reverse distributor of, only those controlled dangerous substances authorized in his registration.(c) Registration under 13:45H-1.2(c) shall be issued to authorize the registrant to dispense controlled dangerous substances in Schedules II, III, IV, or V by Schedules. Any person desiring to obtain a registration to dispense shall specify the Schedules for which he wishes to be registered in his application and may dispense only those controlled dangerous substances in the Schedules included in his registration.(d) Every practitioner registered to dispense controlled dangerous substances who desires to conduct research with substances included in Schedule I or with substances included in Schedules II through V shall make a separate application and be issued a separate registration to conduct such research. Such practitioner shall, in addition to the general requirements of these regulations, furnish the Drug Control Unit with a copy or photocopy of his Federal registration or Federal authorization to conduct research with such substances and a copy of the research protocol.(e) A practitioner registered to dispense controlled dangerous substances may conduct research with nonnarcotic substances in Schedules II through V which are included in his registration without applying for a separate registration to conduct research.(f) A practitioner not registered to dispense may be registered to conduct research only for the purpose of making a laboratory analysis of substances to determine the presence of controlled dangerous substances. Such registrant may not possess or have under his control any controlled dangerous substance except such amounts as are reasonably necessary to make such analysis on the premises of the registered location.(g) A person registered to manufacture controlled dangerous substances may distribute those substances which he is authorized to manufacture without obtaining a separate registration, provided that distribution is from the registered location. A person desiring to distribute controlled dangerous substances other than those he is registered to manufacture or from a different location shall obtain a separate registration as a distributor.(h) For purposes of registration, the following activities by a registrant shall not be deemed to require an additional registration for a separate location: 1. An office used by a registered manufacturer, distributor or reverse distributor or his agents or employees to solicit or make sales of controlled dangerous substances, provided that no such substances are contained in or distributed from such office.2. An office used by a registered dispenser where controlled dangerous substances are prescribed, provided that no such substances are administered, delivered, or otherwise dispensed, and no such substances are contained in such office.(i) A person or duly authorized agent registered as a dispenser for the purchasing and dispensing of sodium pentobarbital for the purpose of animal euthanasia shall be limited to registration in Schedule II (sodium pentobarbital) and may possess or have under his or her control such amounts as are reasonably necessary to administer euthanasia on the premises of the registered location.N.J. Admin. Code § 13:45H-1.3
Amended by 47 N.J.R. 2300(a), effective 9/8/2015